Implementation of Systems Medicine across Europe

Similar documents
Translational scientist competency profile

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint

Conclusions on the future of information and communication technologies research, innovation and infrastructures

Priorities for medical research in the UK

A manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation

Horizon Scanning. Why & how to launch it in Lithuania? Prof. Dr. Rafael Popper

EU s Innovative Medical Technology and EMA s Measures

Position Paper on Horizon ESFRI Biological and Medical Research Infrastructures

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

Before I talk through the strategy itself, I want to tell you more about why

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

The Biological and Medical Sciences Research Infrastructures on the ESFRI Roadmap

What s going on at the MRC

EU Research Integrity Initiative

Precision Public Health Call for Proposals

The UK Prevention Research Partnership (UKPRP): Vision, objectives and rationale

Brief presentation of the results Ioana ISPAS ERA NET COFUND Expert Group

Research and Innovation Strategy and Action Plan UPDATE Advancing knowledge and transforming lives through education and research

Security and Risk Assessment in GDPR: from policy to implementation

MCGILL CENTRE FOR THE CONVERGENCE OF HEALTH AND ECONOMICS (MCCHE)

Ministerial Conference on Nuclear Science and Technology: Addressing Current and Emerging Challenges Vienna, November 2018

Health Informatics Basics

2050 Edinburgh City Vision. One Year On

Report on the Results of. Questionnaire 1

COST FP9 Position Paper

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

Draft Plan of Action Chair's Text Status 3 May 2008

Table Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...

Research Development Request - Profile Template. European Commission

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA

FINNISH UNIVERSITIES AND THE HORIZON EUROPE: HOW TO MAKE THE MOST OF THE MISSIONS?

SMART CITIES Presentation

Health Innovation Manchester

The New Delhi Communiqué

International Conference on Research Infrastructures 2014

December Eucomed HTA Position Paper UK support from ABHI

A Science & Innovation Audit for the West Midlands

e-care Living Lab - 5 avenue du Grand Sablon La Tronche - FRANCE Tel: +33 (0)

Address by Mr Koïchiro Matsuura, Director-General of UNESCO, on the occasion of the Opening ceremony of the UNESCO Future Forum

Written response to the public consultation on the European Commission Green Paper: From

Learning Lessons Abroad on Funding Research and Innovation. 29 April 2016

European Union - New Zealand SCIENCE AND TECHNOLOGY COOPERATION ROADMAP Research and Innovation Priorities

topics topics. The societal challenge 'Health, demographic change and well-being' Amalia-Irina Vlad MD PhD Health Directorate DG RTD

Engaging UK Climate Service Providers a series of workshops in November 2014

Science Impact Enhancing the Use of USGS Science

Supporting Innovation through Regulation and Science

GUIDELINES SOCIAL SCIENCES AND HUMANITIES RESEARCH MATTERS. ON HOW TO SUCCESSFULLY DESIGN, AND IMPLEMENT, MISSION-ORIENTED RESEARCH PROGRAMMES

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

The value of innovative pharmaceuticals and the potential for Vietnam. Mr. Koen Kruytbosch, Vice-Chairman of Pharma Group Vietnam 6 th October, 2016

Social Innovation and new pathways to social changefirst insights from the global mapping

FET Flagships in Horizon 2020

Strategic Plan Public engagement with research

CCG Improvement and Assessment Framework 2016/17. Briefing Document

EHR Optimization: Why Is Meaningful Use So Difficult?

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

IMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters!

AGING IN PLACE WORKSHOP

Home Economics Literacy. Professor Donna Pendergast

Enabling ICT for. development

Roadmap for European Universities in Energy December 2016

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

Hamburg, 25 March nd International Science 2.0 Conference Keynote. (does not represent an official point of view of the EC)

Early HTA to inform value driven market access and reimbursement planning

European Charter for Access to Research Infrastructures - DRAFT

Agenda Item 4: Transport Strategy: Vision and Objectives

A Research and Innovation Agenda for a global Europe: Priorities and Opportunities for the 9 th Framework Programme

e-infrastructures for open science

United Nations Environment Programme 12 February 2019* Guidance note: Leadership Dialogues at fourth session of the UN Environment Assembly

Dear Secretary of State Parreira, Dear President Aires-Barros, Dear ALLEA delegates, esteemed faculty of today s workshop,

2. Evidence themes and their importance along the development path

Climate Change Innovation and Technology Framework 2017

Interoperable systems that are trusted and secure

Health & Social Care Industrial Innovation

New Pathways to Social Change - Creating Impact through Social Innovation Research

Towards a Consumer-Driven Energy System

28 March Report of the Working Group on Pharmaceuticals and Public Health of the High Level Committee on Health.

Parkinson s World A transformational project by The Cure Parkinson s Trust

COUNCIL OF THE EUROPEAN UNION. Brussels, 9 December 2008 (16.12) (OR. fr) 16767/08 RECH 410 COMPET 550

Industrial Strategy Green Paper Response from The Institute of Cancer Research, London

Beatrix Wepner & Susanne Giesecke

Framework Programme 7

DR ANDREA PAVLICKOVA EUROPEAN SERVICE DEVELOPMENT MANAGER NHS 24, SCOTLAND

As our state s flagship university, KU s MISSION is to lift students and society

Research Centers. MTL ANNUAL RESEARCH REPORT 2016 Research Centers 147

Social Innovation 2015: Pathways to Social Change Vienna, November 18 th, Maria Schwarz-Woelzl (ZSI) & Wolfgang Haider (ZSI)

estec PROSPECT Project Objectives & Requirements Document

NHS Next Stage Review: Innovation

Current state of the debate regarding the role of Social Sciences and Humanities in Research and Innovation in the EU 1

Technology and Innovation in the NHS Highlands and Islands Enterprise

2nd Call for Proposals

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

Global Alzheimer s Association Interactive Network. Imagine GAAIN

Scoping Paper for. Horizon 2020 work programme Societal Challenge 4: Smart, Green and Integrated Transport

Technology and Innovation in the NHS Scottish Health Innovations Ltd

The Dutch National Research Agenda

Transcription:

THE CASyM ROADMAP Implementation of Systems Medicine across Europe A short roadmap guide 0

The road toward Systems Medicine A new paradigm for medical research and practice There has been a data generation revolution in modern life science technologies and we need a revolution in using that data to drive forward health and develop a revolutionized new medicine (David Harrison). The nation states of the European Union face unprecedented challenges as a result of an ageing population, re-emergence of infection as a global threat, increased needs for social care and a growing burden of curing and caring for patients with chronic diseases such as cancer, diabetes and neurodegeneration. As well as the health of European citizens being at stake there is a huge economic challenge in making rapid, affordable and effective interventions widely available. The concept of P4 Medicine has grown in stature; encompassing personalised, predictive, obesity, needs some method to predict and choose the best intervention, rather than having to wait for 10 or 15 years to assess outcomes. Participation of patients in health must be more fundamental than simply personalizing medicine; it must be about empowering citizens to be responsible and engaged in protecting their own health and the health and well-being of the communities where they live and work. Research has thrived; technology has revolutionized laboratory, clinical and community based research. Data abounds, but we urgently Systems Medicine is a way of thinking, a conceptual framework, focused on outcome and impact, rather than a theoretical discipline; it aims at a measurable improvement of patient health through systems approaches. participatory and preventive medicine. Most emphasis has perhaps been put on personalized medicine, because it is readily understood and appeals to patients desire for highly customized treatment. However, it would be a mistake to believe that personalized medicine alone can meet all the needs of Europe s health economy: the development of new drugs for cancer, cardiovascular disease and dementia must be made faster, cheaper and more effective before personalizing them: The design of effective interventions, for example to control need to be able to take these data and turn them into information that is useful for the personalization of medicine, prediction of new interventions that will work, participation of citizens in taking responsibility for their own health, and design and implementation of efficient preventive measures to preserve wellbeing based on rationally designed strategies. The need is pressing to implement methods and approaches, and in particular to close the gap between data generation and storage and real impact in the clinic and community. We have had a revolution in the 1

generation of data; we need a revolution in using these data to drive health forward. The roadmap to Systems Medicine offers the means to that end; to change how we engage our citizens to use data of both the healthy and unhealthy; to think about prediction and prevention; and ultimately to journeys may be short and simple, whilst others may be full expeditions requiring extensive preparation, commitment and expense. But, whatever the destination or the journey is, the roadmap can help to navigate roads are new and scarcely travelled. So rather than being prescriptive, the CASyM The CASyM roadmap represents a practical implementation guide for Systems Medicine it offers an overarching conceptual framework through which Systems Medicine can be implemented as a holistic methodological approach in practice. improve the lives of individuals. Already progress has been made, for example in development of predictive tests that allow the personalisation of new anti-cancer drugs, but arguably this is personalization for a disease type rather than a person, and this incremental, case-by-case approach will become unaffordable for the big challenges facing us. When discussing Systems Medicine a common question is its definition. Is it simply systems biology applied to medicine? Is it an overarching term to describe the advent of high throughput -omics, the era of functional genomics? Does it require computational modelling; are we trying to model in silico what will happen in real life? Is it static or is it dynamic, recognising that the course of patient s life changes, and that disease itself changes and adapts over time? Our response is that whilst we can define it as an academic subject, it is much more important to appreciate that systems medicine is an approach, a way of thinking, a conceptual framework, focussed on how a holistic view of patient and disease can change outcome and impact. A roadmap is intended for use when the intended destination is known: it describes a route, or possibly several different routes, to arrive at the destination. Perhaps just as importantly, a good roadmap allows the traveller to join or leave the highway at different points: some Roadmap for Systems Medicine is an invitation to citizens, policy makers, funders, scientists, clinicians and industry to specify a destination and set out on a journey with a new over-arching conceptual framework to turn information into action, to inform the future of healthcare and medicine, drawing upon the participation of the healthy and unhealthy, to prevent disease in populations as well as individuals, to predict the effectiveness of drug development and improve drug trials and other therapeutics interventions, and to truly personalise medicine to the needs of a person, not just a disease. David Harrison is chair of the CASyM Steering Committee and professor of pathology at the University of St Andrews, Scotland. 2

A roadmap for Systems Medicine The CASyM roadmap is the result of a broad cross-disciplinary stakeholder consultation process. It identifies four core priority actions (1) community building, (2) investment in These areas, including patient stratification, the design of clinical trials, and clinical data access, -sharing and -standardization, involvement of industry, development of the necessary technical infrastructure and multidisciplinary training. They are set out along with cross-cutting priority actions and recommendations over a period of 2, 5 and 10 years. The roadmap asserts that investment in proof of concept/pilot studies will help to precipitate a paradigm shift in the way medicine is practiced. This shift will be supported by a strong Systems Medicine community, new multidisciplinary training programmes and the development of new European-wide practices in clinical data access, sharing and standardisation. By building on current national and Clinical needs are the driver for Systems Medicine and the roadmap aims to identify areas where a systems approach can solve clinical problems. proof of concept/pilot studies, (3) crossdisciplinary training and (4) European-wide practices in clinical data access, sharing and standardisation as well as ten key areas necessary to the successful implementation of Systems Medicine in Europe. international efforts in Systems Medicine, and the coalescing of the many stakeholder groups, it is anticipated that this coordinated action will bring significant and sustained benefits to the European citizen, both in sickness and in health. 3

How do we get there? The crucial point for a general acceptance of the Systems Medicine approach is a common understanding of its breadth and clinical applicability. CASyM aims to translate this understanding into a guide for the development and implementation of Systems Medicine. The roadmap does not seek a prescriptive focus on specific diseases; rather it promotes any systems medical work that shows the clinical utility of Systems Medicine. Links to the European Commission, a core stakeholder straddling the spheres of funding and policy, are vital to ensure that the road map can effectively lead the new way to a new thinking about medicine and medical research. The road map aims to build on the existing strong relationships between the EC and key actors within Systems Medicine. Cooperation with other initiatives, patient interest groups as well as regulatory agencies and health care organizations are crucial for the successful implementation of Systems Medicine. Accompanying initiatives and projects that initiate, fuel and sustain the implementation of Systems Medicine across are the ERA-Net ERACoSysMed, the first Systems Medicine oriented ERA-NET under the EC Horizon2020 framework program, that is based in part on the CASyM roadmap and the European Association of Systems Medicine, which will be launched by CASyM in the fall of 2015. 4

Further readings An actual copy of the complete CASyM roadmap can be downloaded at: https://www.casym.eu/index.php?index=90 Information about the ERA-NET ERACoSysMed can be found at: https://www.eracosysmed.eu 5

Imprint Responsible work package This document is part of CASyM work package 1: Developing a roadmap towards an integrative European Systems Medicine strategy and work package 6: Networking and disseminating the CASyM concept and its achieved results. Funding CASyM is funded by the European Union, Seventh Framework Programme under the Health Cooperation Theme and Grant Agreement # 305033. Publisher CASyM administrative Office on behalf of the CASyM consortium Project Management Jülich, Forschungszentrum Jülich GmbH, Germany Marc Kirschner, m.kirschner@fz-juelich.de August 2015 Administrative Office (Coordination) Marc Kirschner - Project Management Jülich, Forschungszentrum Jülich GmbH, Germany Picture credits P1: Ablestock.com/Thinkstock P2: Steve Debenport/iStockphoto.com P3: Nicolas Holzapfel/iStock/Thinkstock 6

7